DEXCOM, INC. Deferred Income Tax Assets, Net
DEXCOM, INC. (DXCM) had Deferred Income Tax Assets, Net of $304.10 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-07-30
- 2026-06-30: Deferred Income Tax Assets, Net $304.10M.
- 2026-03-31: Deferred Income Tax Assets, Net $296.10M.
- 2025-12-31: Deferred Income Tax Assets, Net $295.60M.
- 2025-09-30: Deferred Income Tax Assets, Net $375.60M.
| Period end | Deferred Income Tax Assets, Net | Deferred Income Tax Assets, Net as first filed |
|---|---|---|
| 2026-06-30 | $304.10M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $296.10M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $295.60M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $375.60M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $496.30M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $487.30M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $481.20M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $486.50M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $475.80M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $460.70M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $419.40M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $501.30M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $417.00M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $349.10M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $341.20M 10-K · filed 2024-02-08 | |
| 2022-09-30 | $342.30M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $309.50M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $290.80M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $290.50M 10-K · filed 2023-02-09 | $220.80M 10-K · filed 2022-02-14 |
| 2021-09-30 | $216.30M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $216.40M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $216.70M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $307.70M 10-K · filed 2023-02-09 | $216.40M 10-K · filed 2021-02-11 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |